Glioblastoma (GBM) is characterized by marked heterogeneity, glioma stem-like cells (GSCs), and resistance to therapy. Because GSCs share features with neural progenitor cells (NPCs), we investigated whether neurodevelopmental programs contribute to their response to irradiation. Transcriptional profiling of four patie...
L. Van Eupen, E. Etlioglu, K. Tabury et al.· bioRxiv· 0 citations
Glioblastoma (GBM) is an aggressive primary brain tumor with a major unmet medical need. Oncolytic viruses (OVs) show promise for GBM treatment, but complete remissions remain rare. The intratumoral heterogeneity of GBM drives therapeutic escape and emergence of OV-resistant subclones. Beyond the well-characterized int...
T. Deconinck, T. Dierckx, F. De Smet et al.· bioRxiv· 0 citations
The development of new therapeutics and the validation of pathogenetic cancer mechanisms require representative laboratory models1,2. However, existing collections represent only a fraction of the diversity observed in human cancer2, 3–4. Recent technologies have enabled efficient in vitro model derivation (for example...
Dina Elharouni, Mushriq Al-Jazrawe, Seongmin Choi et al.· Nature· 3 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.